SI1071418T1 - New treatments for nervous disorders - Google Patents

New treatments for nervous disorders

Info

Publication number
SI1071418T1
SI1071418T1 SI9930684T SI9930684T SI1071418T1 SI 1071418 T1 SI1071418 T1 SI 1071418T1 SI 9930684 T SI9930684 T SI 9930684T SI 9930684 T SI9930684 T SI 9930684T SI 1071418 T1 SI1071418 T1 SI 1071418T1
Authority
SI
Slovenia
Prior art keywords
new treatments
nervous disorders
reboxetine
noradrenaline reuptake
new
Prior art date
Application number
SI9930684T
Other languages
English (en)
Slovenian (sl)
Inventor
Adriana Dubini
John Michael Mccall
Duncan Paul Taylor
Voigtlander Philip F. Von
Erik Ho Fong Wong
Original Assignee
Pharmacia Italia S.P.A.
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia S.P.A., Pharmacia & Upjohn Company filed Critical Pharmacia Italia S.P.A.
Publication of SI1071418T1 publication Critical patent/SI1071418T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI9930684T 1998-04-13 1999-04-02 New treatments for nervous disorders SI1071418T1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8163298P 1998-04-13 1998-04-13
IT98MI000870 IT1305322B1 (it) 1998-04-23 1998-04-23 Uso di reboxetina per il trattamento di disturbi nervosi
US8503398P 1998-05-11 1998-05-11
EP99918423A EP1071418B1 (en) 1998-04-13 1999-04-02 New treatments for nervous disorders
PCT/US1999/004288 WO1999052518A2 (en) 1998-04-13 1999-04-02 New treatments for nervous disorders

Publications (1)

Publication Number Publication Date
SI1071418T1 true SI1071418T1 (en) 2005-04-30

Family

ID=11379879

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930684T SI1071418T1 (en) 1998-04-13 1999-04-02 New treatments for nervous disorders

Country Status (25)

Country Link
US (1) US6391876B1 (xx)
EP (1) EP1071418B1 (xx)
JP (1) JP2002511408A (xx)
KR (1) KR100555279B1 (xx)
CN (1) CN1197569C (xx)
AT (1) ATE277617T1 (xx)
AU (1) AU755612B2 (xx)
BR (1) BR9909476A (xx)
CA (1) CA2320722A1 (xx)
DE (1) DE69920679T2 (xx)
DK (1) DK1071418T3 (xx)
EA (1) EA003546B1 (xx)
ES (1) ES2228035T3 (xx)
HU (1) HUP0101748A3 (xx)
IL (1) IL138887A0 (xx)
IT (1) IT1305322B1 (xx)
NO (1) NO20005131D0 (xx)
NZ (1) NZ507693A (xx)
PL (1) PL194039B1 (xx)
PT (1) PT1071418E (xx)
SI (1) SI1071418T1 (xx)
SK (1) SK14482000A3 (xx)
TR (1) TR200002970T2 (xx)
WO (1) WO1999052518A2 (xx)
ZA (1) ZA200004480B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500827B2 (en) * 1998-05-08 2002-12-31 Pharmacia & Upjohn Company Drug combinations
CA2643231A1 (en) 1999-07-01 2001-01-11 Pharmacia & Upjohn Company Norepinephrine reuptake inhibitors and methods of using the same
EP1500396B1 (en) * 1999-07-01 2005-09-28 Pharmacia & Upjohn Company LLC Reboxetine for treating migraine headaches
EA200300567A1 (ru) * 2000-11-15 2004-10-28 Эли Лилли Энд Компани Лечение состояний тревоги
CN1662511B (zh) * 2002-06-17 2010-06-09 辉瑞意大利公司 瑞波西汀的药物盐
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en) 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
GB2167407B (en) 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
WO1999020279A1 (en) 1997-10-17 1999-04-29 Eli Lilly And Company Potentiation of pharmaceuticals

Also Published As

Publication number Publication date
EA200001058A1 (ru) 2001-04-23
AU3635199A (en) 1999-11-01
PL194039B1 (pl) 2007-04-30
KR100555279B1 (ko) 2006-03-03
EA003546B1 (ru) 2003-06-26
CN1293569A (zh) 2001-05-02
ATE277617T1 (de) 2004-10-15
PT1071418E (pt) 2004-12-31
IL138887A0 (en) 2001-11-25
DE69920679D1 (de) 2004-11-04
WO1999052518A3 (en) 1999-12-02
ZA200004480B (en) 2002-04-24
HUP0101748A2 (hu) 2001-11-28
IT1305322B1 (it) 2001-05-04
PL346294A1 (en) 2002-01-28
DE69920679T2 (de) 2006-03-02
AU755612B2 (en) 2002-12-19
JP2002511408A (ja) 2002-04-16
ES2228035T3 (es) 2005-04-01
CN1197569C (zh) 2005-04-20
EP1071418B1 (en) 2004-09-29
BR9909476A (pt) 2000-12-19
NO20005131L (no) 2000-10-12
SK14482000A3 (sk) 2001-08-06
NZ507693A (en) 2003-08-29
TR200002970T2 (tr) 2001-01-22
US6391876B1 (en) 2002-05-21
EP1071418A2 (en) 2001-01-31
ITMI980870A1 (it) 1999-10-23
WO1999052518A2 (en) 1999-10-21
KR20010042641A (ko) 2001-05-25
CA2320722A1 (en) 1999-10-21
NO20005131D0 (no) 2000-10-12
DK1071418T3 (da) 2005-01-03
HUP0101748A3 (en) 2001-12-28

Similar Documents

Publication Publication Date Title
IL138887A0 (en) New treatments for nervous disorders
UA43385C2 (uk) Спосіб лікування синдрому дефіциту уваги/гіперактивності
MY134110A (en) Combinations of reboxetine and neuroleptic agents
ES2166110T3 (es) Agonistas no alostericos de gabaa para tratar trastornos del sueño.
WO2001062236A3 (en) New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent
PT739212E (pt) Utilizacao de interleucina-12 para a prevencao de doenca causada pela reaccao do enxerto contra o hospedeiro
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
ATE329588T1 (de) Verwendung von sibutramin zur behandlung von von organischen störungen verursachten zns- erkrankungen
SI1225881T1 (sl) Uporaba dapoksetina, selektivnega zaviralca ponovnega privzema serotonina s hitrim pricetkom delovanja, za zdravljenje seksualne disfunkcije
PL402987A1 (pl) Enancjomer (1S, 2R) milnacypranu do wytwarzania leku
WO2002077198A8 (en) Methods of modulating angiogenesis
BR0208040A (pt) Derivados de benzofuran-2-carboxamidas substituìdas
MY143278A (en) Treatment of neurotic disorders.
WO2002040006A3 (en) Treatment of anxiety disorders
MY136367A (en) Treatment of cognitive failure
PT1075264E (pt) Novas combinacoes farmacologicas de reboxetina e pindolol
EP0756869A3 (en) Use of duloxetine or of N-alkyl-3-phenyl-(2-alkylthiophenoxy)-propylamines for treating attention-deficit/hyperactivity disorder
CO4950552A1 (es) Nueva composicion lectivos de la reabsorcion de seotonina y un bloqueador b
PL337996A1 (en) Method of treating and preventing cardiac disorders using a selective serotonin reuptake inhibitor (ssri)
PT1054671E (pt) Nova utilizacao da ropivacaina para o controlo da dor
ES2122953T1 (es) Utilizacion de inhibidores pkc para la fabricacion de un medicamento para el tratamiento de las disfunciones sexuales.
ZA991638B (en) Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders and autism.
PT1282414E (pt) Compostos derivados de felbamato para o tratamento da dor neuropatica
ECSP992873A (es) Metodo para tratar desordenes compulsivos, obsesivos, desordenes somatoformes, desordenes disociativos, desordenes al comer, desordenes de control de impulso, y autismo (caso cn0823)